Navigation Links
Sequenom Announces Participation At The J.P. Morgan 32nd Annual Healthcare Conference
Date:1/6/2014

SAN DIEGO, Jan. 6, 2014 /PRNewswire/ --Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative diagnostic testing and genetic analysis solutions, today announced the Company's participation at the J.P. Morgan 32nd Annual Healthcare Conference at the Westin St. Francis Hotel in San Francisco, California on January 13-16, 2014.

(Logo: http://photos.prnewswire.com/prnh/20040415/SQNMLOGO)

Harry Hixson, Chairman and CEO, William Welch, President and COO, and Paul V. Maier, Chief Financial Officer, will present on Thursday, January 16, 2014 beginning at 2:00 p.m. PT, and provide an overview of and update on the Company. The presentation is expected to last approximately 30 minutes and will be an audio webcast live through the "Invest" section of the Sequenom Web site at www.sequenom.com. An audio replay will be available for 90 days following the initial presentation. 

About Sequenom
Sequenom, Inc. (NASDAQ: SQNM) is a life sciences company committed to improving healthcare through revolutionary genomic and genetic analysis solutions. Sequenom develops innovative technology, products and diagnostic tests that target and serve discovery and clinical research, and molecular diagnostic markets. The company was founded in 1994 and is headquartered in San Diego, California. Sequenom maintains a Web site at http://www.sequenom.com to which Sequenom regularly posts copies of its press releases as well as additional information about Sequenom. Interested persons can subscribe on the Sequenom Web site to email alerts or RSS feeds that are sent automatically when Sequenom issues press releases, files its reports with the Securities and Exchange Commission or posts certain other information to the Web site.


'/>"/>
SOURCE Sequenom, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Sequenom, Inc. Reports Financial Results For The Third Quarter Of 2013
2. Ariosa Diagnostics Wins Summary Judgment Against Sequenom on Cell-free DNA Patent
3. Sequenom, Inc. Announces Date Of Third Quarter 2013 Financial Results And Conference Call
4. Sequenom Announces Global Certified Service Provider Program
5. Sequenom Announces Participation At The Wedbush 2013 Life Sciences Management Access Conference
6. Sequenom And CombiMatrix Announce Collaboration Agreement To Market Chromosomal Microarray Analysis For Prenatal Testing
7. Todays Research: Inovio Pharma, Sequenom, Peregrine Pharma, Onyx Pharma, and Optimer Pharma
8. Sequenom Announces License And Marketing Agreements With Laboratoire Cerba In France
9. Sequenom, Inc. Reports Financial Results For The First Quarter Of 2013
10. Sequenom Announces Participation At The Bank Of America Merrill Lynch Health Care Conference
11. Morning Research on Sequenom, Peregrine Pharma, Onyx Pharma, and Inovio Pharma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2017)...  Getinge, a leading global provider of products ... cost efficiency within healthcare and life sciences, today ... demonstrating that intra-aortic balloon counterpulsation (IABC) appears effective ... The single-center, retrospective, observational study showed that use ... 50cc intra-aortic balloon (IAB) in contemporary practice ...
(Date:5/2/2017)... NEW YORK and LONDON ... leading distributor of market intelligence, MarketResearch.com is pleased to ... Reimbursement Consulting AB that allows for the marketing ... proprietary market analyses through the MarketResearch.com website. ... easy access to complete product descriptions and tables of ...
(Date:5/2/2017)... Iowa , May 2, 2017  CIVCO ... patient-centric radiotherapy solutions, announced today that Nat ... been with CIVCO since 2012 and has served ... management, senior vice president and general manager, and ... "I am extremely proud of what ...
Breaking Medicine Technology:
(Date:5/26/2017)... ... ... “Just What Happened in the Garden of Eden”: retells the stories of three Bible figures ... of published author, Penelope Colt, mother, trader, horse farmer, artist and a former GM journeyman. ... three. At six, they moved to Dayton, Ohio, where Penny graduated high school. ...
(Date:5/24/2017)... , ... May 24, 2017 , ... ... background. Understanind and choosing the most appropriate instruments for research and understanding the ... research finding. This webinar will focus on innovations in stereo microscopy for brightfield ...
(Date:5/24/2017)... , ... May 24, 2017 , ... ... implants in Bayside, NY, who have now spent 10 years as clinical instructors ... York University (NYU) College of Dentistry. Through the program, private practitioners receive cutting-edge ...
(Date:5/24/2017)... ... ... Myers Jackson is well known for auctioning homes that people move and flip. ... planet. The luxury home market is alive and well and there are mansions for ... “11 Spyglass Hill Auction will enlighten you on the dynamics of how to market ...
(Date:5/24/2017)... ... May 24, 2017 , ... Accordant Technology, a trusted IT ... delivers an analytics-first approach, layered with machine learning, that provides real-time visibility into ... the cloud to the edge. Through the new partnership, customers get the real-time ...
Breaking Medicine News(10 mins):